Timothy Hunt to take helm of ARM as new CEO August 11, 2022 -- The Alliance for Regenerative Medicine (ARM) has announced that Timothy Hunt will succeed Janet Lambert as chief executive officer (CEO) of the Washington, DC-based advocacy organization, which represents the cell and gene therapy industry.Read More
Gene therapy shows promise in treating ALS in rodent models August 2, 2022 -- A gene therapy, patented through the University of California, San Diego and the Department of Veterans Affairs measurably delayed disease onset in humanized mouse and rat models of familial amyotrophic lateral sclerosis (ALS).Read More
Scientists win $36.5M for cardiac gene editing therapy August 1, 2022 -- An international team won 30 million pounds ($36.5 million U.S.) to develop cures for inherited heart muscle diseases that use ultra-precise gene therapy technologies to edit or silence the faulty genes that cause the conditions.Read More
Linus survey finds top two techniques or applications in life sciences R&D July 29, 2022 -- A new survey of scientists finds that the top two techniques or applications in life sciences research and development (R&D) are CRISPR/cell-line engineering and artificial intelligence/machine learning-enabled bioinformatics when it comes to driving scientific advancements.Read More
Genes explain the effects of psychedelic drugs July 28, 2022 -- Not everyone has the same response to psychedelic drugs and North Carolina researchers have figured out why -- seven genetic variants of one serotonin receptor greatly impact a certain serotonin receptor’s structure and function.Read More